Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Brief depressive affect].

H J Gertz1

  • 1Psychiatrische Klinik und Poliklinik, Freien Universität Berlin.

Der Nervenarzt
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

A 59-year-old experienced a depressive episode followed by weekly recurring depressive attacks. Carbamazepine effectively treated these episodes, offering a potential therapeutic option.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment.

The journal of nutrition, health & aging·2009
Same author

Critical evaluation of self-rated quality of life in mild cognitive impairment and Alzheimer's disease--further evidence for the impact of anosognosia and global cognitive impairment.

The journal of nutrition, health & aging·2009
Same author

[MCI-plus: mild cognitive impairment with rapid progression. Part II: Biomarkers and research methods].

Deutsche medizinische Wochenschrift (1946)·2009
Same author

[MCI-plus: mild cognitive impairment with rapid progression. Part I: prevention and therapy].

Deutsche medizinische Wochenschrift (1946)·2008
Same author

[Mild cognitive impairment with predictors of rapid decline].

Deutsche medizinische Wochenschrift (1946)·2008
Same author

Hippocampal atrophy in Alzheimer disease: age matters.

Neurology·2006
Same journal

[Psychotropic drug research in Germany: challenges of early benefit assessment and precision psychiatry].

Der Nervenarzt·2026
Same journal

[When brain abscesses run in the family…].

Der Nervenarzt·2026
Same journal

[Digital health applications and adherence in depression: a qualitative study from the perspective of healthcare providers].

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
Same journal

[Rare genetic diseases with frequent mental symptoms].

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
See all related articles

Area of Science:

  • Neurology
  • Psychiatry

Background:

  • Depressive episodes can manifest with varying durations and frequencies.
  • Recurrent depressive attacks pose a significant clinical challenge.

Observation:

  • A 59-year-old patient presented with a three-month depressive episode.
  • Subsequently, the patient experienced weekly to tri-weekly depressive attacks lasting 30-60 minutes.

Findings:

  • Carbamazepine demonstrated successful treatment outcomes for the patient's recurrent depressive attacks.
  • This suggests carbamazepine's efficacy in managing specific types of depressive episodes.

Implications:

  • Carbamazepine may be a viable treatment option for patients with similar presentations of recurrent depressive attacks.
  • Further research is warranted to explore the neurobiological mechanisms underlying carbamazepine's effectiveness in this context.